Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Aude Garcel
Observed names:
A Garcel,
A. Garcel,
GARCEL, Aude,
Garcel, Aude
Institution:
Abivax (France)
Observed institutions:
University of Geneva,
Centre National de la Recherche Scientifique,
Université de Montpellier,
Service de Santé des Armées,
Institut de Génétique Moléculaire de Montpellier,
Institut de Biologie Structurale,
Abivax (France),
University of Lausanne
show all 8
ORCID:
0000-0002-1347-9626
Observed ORCID:
0000-0002-1347-9626
OpenAlex ID:
A5075949268
Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis
2015
·
Noëlie Campos
, Renier Myburgh
, et al.
·
Retrovirology
·
102
PDF
Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing
2019
·
Audrey Vautrin
, Laurent Manchon
, et al.
·
Scientific Reports
·
68
PDF
Specific and selective induction of miR-124 in immune cells by the quinoline ABX464: a transformative therapy for inflammatory diseases
2020
·
Jamal Tazi
, Christina Begon-Pescia
, et al.
·
Drug Discovery Today
·
56
PDF
Adenovirus Dodecahedron Allows Large Multimeric Protein Transduction in Human Cells
2003
·
P. Fender
, G. Schoehn
, et al.
·
Journal of Virology
·
40
Protein transduction into human cells by adenovirus dodecahedron using WW domains as universal adaptors
2006
·
A. Garcel
, E. Gout
, et al.
·
The Journal of Gene Medicine
·
38
The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages
2017
·
Karim Chebli
, Laura Papon
, et al.
·
Scientific Reports
·
37
PDF
Genomic sequence of a clonal isolate of the vaccinia virus Lister strain employed for smallpox vaccination in France and its comparison to other orthopoxviruses
2007
·
Aude Garcel
, Jean-Marc Crance
, et al.
·
Journal of General Virology
·
34
ABX464 (Obefazimod) Upregulates miR-124 to Reduce Proinflammatory Markers in Inflammatory Bowel Diseases
2022
·
Cécile Apolit
, Noëlie Campos
, et al.
·
Clinical and Translational Gastroenterology
·
31
Specific Targeting of the F13L Protein by St-246 Affects Orthopoxvirus Production Differently
2008
·
Sophie Duraffour
, Solenne Vigne
, et al.
·
Antiviral Therapy
·
25
Phenotypic and genetic diversity of the traditional Lister smallpox vaccine
2008
·
Aude Garcel
, Julien Perino
, et al.
·
Vaccine
·
16
Vaccinia virus-induced smallpox postvaccinal encephalitis in case of blood–brain barrier damage
2012
·
Aude Garcel
, William Fauquette
, et al.
·
Vaccine
·
13
In vitro blood brain barrier models as a screening tool for colloidal drug delivery systems and other nanosystems
2010
·
Aude Garcel
, Sophie Martel
, et al.
·
International Journal of Biomedical Nanoscience and Nanotechnology
·
6
RNA sequencing analysis of activated macrophages treated with the anti-HIV ABX464 in intestinal inflammation
2017
·
Laurent Manchon
, Karim Chebli
, et al.
·
Scientific Data
·
5
PDF
Thu0199 Abx464, a Novel Drug in the Field of Inflammation, Increases Mir-124 and Modulates Macrophages and T-cell Functions.
2020
·
C. Begon-Pescia
, J. Mielle
, et al.
·
Annals of the Rheumatic Diseases
·
4
PDF
OP30 Obefazimod shows first evidence of anti-fibrotic activity in preclinical models of inflammatory bowel disease
2026
·
S Danese
, F Magro
, et al.
·
Journal of Crohn s and Colitis
·
3
P0090 Synergistic reduction of inflammatory cytokines with obefazimod and etrasimod in combination treatment vs. either monotherapy in a mouse model of inflammatory bowel disease
2025
·
A Garcel
, F Cataldi
, et al.
·
Journal of Crohn s and Colitis
·
1
Smallpox post-vaccinal encephalitis: vaccinia virus interaction with the blood brain barrier
2008
·
Aude Garcel
, William Fauquette
, et al.
·
BMC Proceedings
·
1
PDF
Tu1433 OBEFAZIMOD SHOWS FIRST EVIDENCE OF DUAL ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITY IN MURINE IN VIVO AND HUMAN IN VITRO MODELS
2026
·
Silvio Danese
, Fernando Magro
, et al.
·
Gastroenterology
Tu1433 OBEFAZIMOD SHOWS FIRST EVIDENCE OF DUAL ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITY IN MURINE IN VIVO AND HUMAN IN VITRO MODELS
2026
·
Silvio Danese
, Fernando Magro
, et al.
·
Gastrointestinal Endoscopy
649: Synergistic Reduction of Inflammatory Cytokines With Obefazimod and Etrasimod in Combination Treatment Vs. Either Monotherapy in a Mouse Model of Inflammatory Bowel Disease
2025
·
Aude Garcel
, Fabio Cataldi
, et al.
·
Gastroenterology
Sa1238 OBEFAZIMOD REDUCES TOTAL NUMBER OF TUMORS AND HIGH-GRADE ADENOMAS IN A MURINE COLITIS ASSOCIATED COLORECTAL CANCER MODEL
2024
·
Cécile Apolit
, Bénédicte Lemmers
, et al.
·
Gastroenterology
Targeting the Long Non-Coding RNA LINC00599-205 Splicing by Novel Candidate Drug ABX464 To Produce the Anti-Inflammatory MicroRNA MiR-124
2020
·
Laurent Manchon
, Audrey Vautrin
, et al.
·
American Journal of Biomedical Science & Research
PDF
Targeting the Long Non-Coding RNA LINC00599-205 splicing by novel candidate drug ABX464 to produce the anti-inflammatory microRNA miR-124
2019
·
Manchon, Laurent
, Vautrin, Audrey
, et al.
·
HAL
Targeting Long Non-Coding RNA splicing by novel candidate drug
2019
·
Laurent Manchon
, Audrey Vautrin
, et al.
·
IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
Eclairages dur le mode d'action de la molécule ST-246
2008
·
Sophie Duraffour
, S Vigne
, et al.
·
Abstract book
Show more works
View as search
Works count:
28
Citation count:
480
H-index:
11
I10-index:
11
Year
Topic
Type
